Fig. 8 | Scientific Reports

Fig. 8

From: Outcome prediction model for patients with unresectable hepatocellular carcinoma treated with targeted therapy

Fig. 8

Comparisons of the AUCs of the different predictive models at 1, 2, and 3 years for A OS and B PFS in the validation cohort. DCA of the models in predicting C OS and D PFS in the entire cohort. TUHP targeted therapy for unresectable hepatocellular prognosis, OS overall survival, PFS progression-free survival; BCLC Barcelona Clinic Liver Cancer, CNLC Chinese Liver Cancer, HAP Hepatoma Arterial Embolization Prognostic system, PROSASH-II Prediction of Survival in Advanced Sorafenib-Treated Hepatocellular Carcinoma-II, AUC area under the curve, PFS progression-free survival, DCA decision curve analysis.

Back to article page